Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe De Wals

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007Geneviève Deceuninck, Caroline Quach, Markos Panagopoulos, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, CanadaPhilippe De Wals, Geneviève Deceuninck, Brigitte Lefebvre, et al.
The Journal of Infection|May 2, 2021
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccinationFederico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, et al.
Journal of Clinical Microbiology|February 17, 2012
Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003Jianwei Zhou, Brigitte Lefebvre, Saul Deng, et al.
Vaccine|February 21, 2021
Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North AmericaArto A Palmu, Philippe De Wals, Maija Toropainen, et al.
Vaccine|March 4, 2017
Policy making for vaccine use as a driver of vaccine innovation and development in the developed worldKatherine Seib, Andrew J Pollard, Philippe de Wals, et al.
Vaccine|September 8, 2021
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, CanadaJacques Pépin, Annie-Claude Labbé, Alex Carignan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational StudiesHeather L Sings, Philippe De Wals, Bradford D Gessner, et al.
Msphere|December 7, 2018
A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in QuebecRodica Gilca, Philippe De Wals, Sheila M Nolan, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007Geneviève Deceuninck, Caroline Quach, Markos Panagopoulos, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, CanadaPhilippe De Wals, Geneviève Deceuninck, Brigitte Lefebvre, et al.
The Journal of Infection|May 2, 2021
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccinationFederico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, et al.
Journal of Clinical Microbiology|February 17, 2012
Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003Jianwei Zhou, Brigitte Lefebvre, Saul Deng, et al.
Vaccine|February 21, 2021
Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North AmericaArto A Palmu, Philippe De Wals, Maija Toropainen, et al.
Vaccine|March 4, 2017
Policy making for vaccine use as a driver of vaccine innovation and development in the developed worldKatherine Seib, Andrew J Pollard, Philippe de Wals, et al.
Vaccine|September 8, 2021
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, CanadaJacques Pépin, Annie-Claude Labbé, Alex Carignan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational StudiesHeather L Sings, Philippe De Wals, Bradford D Gessner, et al.
Msphere|December 7, 2018
A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in QuebecRodica Gilca, Philippe De Wals, Sheila M Nolan, et al.
Pageof 13